EBITDA: Income before interest, taxes, depreciation and amortization.
Rock Creek Pharmaceuticals, Inc. (RCPIQ) had EBITDA of $-1.91M for the most recently reported fiscal quarter, ending 2016-06-30.
| Income Statement Financials | |
-- |
|
$-2.79M |
|
-- |
|
-- |
|
$2.02M |
|
$-2.02M |
|
$-0.77M |
|
$-2.79M |
|
$-2.79M |
|
$-2.79M |
|
$-2.79M |
|
$-2.79M |
|
$-2.79M |
|
$-2.02M |
|
|
EBITDA |
$-1.91M |
62.00M |
|
62.00M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$0.19M |
|
$0.15M |
|
$11.58M |
|
$11.78M |
|
$22.02M |
|
$2.74M |
|
$2.74M |
|
$24.77M |
|
$-12.99M |
|
$-13.04M |
|
$-12.99M |
|
153.62M |
|
| Cash Flow Statement Financials | |
$-3.98M |
|
-- |
|
$3.74M |
|
$0.49M |
|
$0.18M |
|
$-0.31M |
|
$0.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.01 |
|
-- |
|
-- |
|
-0.27 |
|
-1.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
21.52% |
|
21.44% |
|
-23.73% |
|
27.28% |
|
$-0.08 |
|
$-0.06 |
|
$-0.06 |
|